GV BioSolutions: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GV BioSolutions
Largest movements
- Receivables within one year +€3,803
up €3,803 (+173.3%), from €2,195 to €5,997
of which Trade receivables: +€4,378
- Tangible fixed assets +€1,947
new in 2025: €1,947
- Cash -€1,758
down €1,758 (-24.8%), from €7,074 to €5,316
mainly Receivables within one year (-€3,803) and Trade debts (-€3,006)
- Formation expenses -€827
down €827 (-24.9%), from €3,319 to €2,492
- Reserves +€5,557
new in 2025: €5,557
- Trade debts -€3,006
no longer reported in 2025 (was €3,006)
- Tax, wage and social debts +€2,455
up €2,455 (+132.1%), from €1,859 to €4,314
of which Taxes: +€2,551
- Other debts -€1,971
down €1,971 (-36.1%), from €5,451 to €3,481
- Gross operating margin +€10,713
up €10,713 (+1249.7%), from €857 to €11,570
- Taxes +€2,502
new in 2025: €2,502
- Other operating charges +€1,348
up €1,348 (+2174.5%), from €62 to €1,410
- Financial charges +€934
up €934 (+876.2%), from €107 to €1,041
- Depreciation +€117
up €117 (+14.3%), from €817 to €934
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €13,187 | €16,352 | +€3,165 | +24.0% |
| Formation expenses | 20 | €3,319 | €2,492 | -€827 | -24.9% |
| Fixed assets | 21/28 | €600 | €2,547 | +€1,947 | +324.5% |
| Tangible fixed assets | 22/27 | - | €1,947 | +€1,947 | |
| Plant, machinery and equipment | 23 | - | €1,947 | +€1,947 | |
| Financial fixed assets | 28 | €600 | €600 | = | 0.0% |
| Current assets | 29/58 | €9,268 | €11,313 | +€2,045 | +22.1% |
| Amounts receivable within one year | 40/41 | €2,195 | €5,997 | +€3,803 | +173.3% |
| Trade receivables | 40 | €96 | €4,474 | +€4,378 | +4566.3% |
| Other amounts receivable | 41 | €2,099 | €1,523 | -€576 | -27.4% |
| Cash at bank and in hand | 54/58 | €7,074 | €5,316 | -€1,758 | -24.8% |
| Total equity and liabilities | 10/49 | €13,187 | €16,352 | +€3,165 | +24.0% |
| Equity | 10/15 | €2,871 | €8,557 | +€5,686 | +198.0% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Capital | 10 | €3,000 | - | -€3,000 | |
| Issued capital | 100 | €3,000 | - | -€3,000 | |
| Reserves | 13 | - | €5,557 | +€5,557 | |
| Distributable reserves | 133 | - | €5,557 | +€5,557 | |
| Profit (loss) carried forward | 14 | -€129 | - | +€129 | |
| Amounts payable | 17/49 | €10,316 | €7,795 | -€2,521 | -24.4% |
| Amounts payable within one year | 42/48 | €10,316 | €7,795 | -€2,521 | -24.4% |
| Trade debts | 44 | €3,006 | - | -€3,006 | |
| Suppliers | 440/4 | €3,006 | - | -€3,006 | |
| Taxes, remuneration and social security | 45 | €1,859 | €4,314 | +€2,455 | +132.1% |
| Taxes | 450/3 | €27 | €2,578 | +€2,551 | +9497.0% |
| Remuneration and social security | 454/9 | €1,832 | €1,736 | -€96 | -5.2% |
| Other amounts payable | 47/48 | €5,451 | €3,481 | -€1,971 | -36.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €817 | €934 | +€117 | +14.3% |
| Other operating charges | 640/8 | €62 | €1,410 | +€1,348 | +2174.5% |
| Gross operating margin | 9900 | €857 | €11,570 | +€10,713 | +1249.7% |
| Operating profit (loss) | 9901 | -€22 | €9,226 | +€9,248 | |
| Financial income | 75/76B | €0 | €2 | +€2 | +21600.0% |
| Recurring financial income | 75 | €0 | €2 | +€2 | +21600.0% |
| Financial charges | 65/66B | €107 | €1,041 | +€934 | +876.2% |
| Recurring financial charges | 65 | €107 | €1,041 | +€934 | +876.2% |
| Profit (loss) for the period before taxes | 9903 | -€129 | €8,188 | +€8,316 | |
| Income taxes | 67/77 | - | €2,502 | +€2,502 | |
| Profit (loss) for the period | 9904 | -€129 | €5,686 | +€5,815 | |
| Profit (loss) for the period to be appropriated | 9905 | -€129 | €5,686 | +€5,815 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.